在膀癌中,Hedyotis扩散注射通过CAV1/JUN/VEGFA调节膀癌中的铁亡
Kaiping Bai1, Yanxi Long2, Fei Yuan1
1Department of Urology, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, No. 1678 Dongfang Road, Pudong New Area, Shanghai 200127, China.
International immunopharmacology
|January 7, 2025
概括
赫迪奥蒂斯 (Hedyotis diffusa Willd.) 是一个散的植物. (HDW) 通过诱导铁亡,对膀癌产生抗癌作用. 关键基因CAV1,VEGFA和JUN被确定为这种铁调节的细胞死亡机制的关键基因.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 细胞生物学 细胞生物学
背景情况:
- 赫迪奥蒂斯 (Hedyotis diffusa Willd.) 是一个散的植物. (HDW) 是一种具有已知的抗癌潜力的中国传统药用植物.
- 铁,一种依赖于铁的细胞死亡途径,越来越多地被认为是癌症治疗中的作用.
- HDW对膀癌 (BLCA) 的特定影响和分子机制在很大程度上仍未被探索.
研究的目的:
- 为了研究HDW对膀癌的抗癌作用.
- 阐明潜在的分子机制,特别关注铁灭.
- 在BLCA中确定参与HW诱导的铁亡的关键分子标.
主要方法:
- 进行了体内和体外实验.
- 使用了网络药理学,数据挖掘,转录组和单细胞分析.
- 基因淘汰实验是为了验证目标基因而进行的.
主要成果:
- 通过诱导铁亡,HDW通过诱导铁亡来证明对膀癌的抗癌活性.
- HDW已被证明在体外和体内都能诱导铁.
- 在BLCA中,CAV1,VEGFA和JUN被确定为调解HDW诱导的铁亡的关键基因.
结论:
- HDW通过诱导铁亡,对膀癌产生抗癌作用.
- 已识别的基因CAV1,VEGFA和JUN是这一过程的关键决定因素.
- HDW为膀癌治疗提供了一个有前途的治疗化合物.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


